Posts In: Gubba Pharma In E News

The Indian pharmaceutical industry is in denial over drug-quality charges

July 24, 2019 Gubba Pharma In E News

Katherine Eban’s new book, “Bottle of Lies,” has focused a very intense spotlight on the mostly ignored transgressions of the Indian generic pharmaceutical industry in...

Continue Reading

Bangladesh: Pharma exports soar 26%

July 24, 2019 Gubba Pharma In E News

Skilled manpower and improved quality of medicines and more focus on foreign markets have helped Bangladesh to expand its pharma market to 144 countries. Bangladesh’s...

Continue Reading

Pharma takes Wi-Fi targeting to the doctor’s office to reach waiting patients on their smartphones

July 17, 2019 Gubba Pharma In E News

Checking your phone at the doctor’s office? Don’t be surprised if you get an ad for a drug you can talk to your doctor about....

Continue Reading

German Study Finds Most New Drugs Fail to Improve on Standard of Care

July 17, 2019 Gubba Pharma In E News

A study in The BMJ by officials from Germany’s Institute of Quality and Efficiency in Healthcare (IQWiG) finds there is no evidence of added benefit...

Continue Reading

Dr Reddy’s plan to launch value-added drugs in US

July 17, 2019 Gubba Pharma In E News

Dr Reddy’s Laboratories said that it plans to launch several value-added products, to offset the persisting pricing pressure problem in the US market. As part...

Continue Reading

FDA Accepts Sanofi’s BLA for Meningitis Vaccine to Review

July 10, 2019 Gubba Pharma In E News

Sanofi SNY announced that the FDA has accepted for review its biologics license application (BLA) for MenQuadfi, a meningococcal vaccine candidate, currently being developed for...

Continue Reading

Maersk Spot unveiled as Danish carrier moves ahead with online box bookings

June 27, 2019 Gubba Pharma In E News

Maersk today unveiled the next chapter in its quest to lead liner shipping’s path to online container bookings. With the launch of Maersk Spot, the...

Continue Reading

AbbVie to acquire Botox maker Allergan for $63bn

June 27, 2019 Gubba Pharma In E News

US drugmaker AbbVie has agreed to buy Allergan, the Irish-domiciled maker of Botox, in a $63bn deal that is the sector’s latest blockbuster transaction driven...

Continue Reading

Bharat Biotech to collaborate with Hilleman to develop cholera vaccine

June 27, 2019 Gubba Pharma In E News

Hilleman Laboratories announced on Wednesday that it will collaborate with Hyderabad-based vaccine maker Bharat Biotech International Limited (BBIL) for further development, manufacture and commercialisation of...

Continue Reading